JP2023530600A5 - - Google Patents

Info

Publication number
JP2023530600A5
JP2023530600A5 JP2022573448A JP2022573448A JP2023530600A5 JP 2023530600 A5 JP2023530600 A5 JP 2023530600A5 JP 2022573448 A JP2022573448 A JP 2022573448A JP 2022573448 A JP2022573448 A JP 2022573448A JP 2023530600 A5 JP2023530600 A5 JP 2023530600A5
Authority
JP
Japan
Prior art keywords
cells
evs
antibody
membrane
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022573448A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023530600A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/035072 external-priority patent/WO2021247457A2/en
Publication of JP2023530600A publication Critical patent/JP2023530600A/ja
Publication of JP2023530600A5 publication Critical patent/JP2023530600A5/ja
Priority to JP2025173693A priority Critical patent/JP2026027260A/ja
Pending legal-status Critical Current

Links

JP2022573448A 2020-06-01 2021-05-31 細胞外ベシクルの製造するための方法及びその使用 Pending JP2023530600A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025173693A JP2026027260A (ja) 2020-06-01 2025-10-15 細胞外ベシクルの製造するための方法及びその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063033014P 2020-06-01 2020-06-01
US63/033,014 2020-06-01
PCT/US2021/035072 WO2021247457A2 (en) 2020-06-01 2021-05-31 Methods for making extracellular vesicles and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025173693A Division JP2026027260A (ja) 2020-06-01 2025-10-15 細胞外ベシクルの製造するための方法及びその使用

Publications (2)

Publication Number Publication Date
JP2023530600A JP2023530600A (ja) 2023-07-19
JP2023530600A5 true JP2023530600A5 (enExample) 2024-06-10

Family

ID=76943084

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022573448A Pending JP2023530600A (ja) 2020-06-01 2021-05-31 細胞外ベシクルの製造するための方法及びその使用
JP2025173693A Pending JP2026027260A (ja) 2020-06-01 2025-10-15 細胞外ベシクルの製造するための方法及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025173693A Pending JP2026027260A (ja) 2020-06-01 2025-10-15 細胞外ベシクルの製造するための方法及びその使用

Country Status (13)

Country Link
US (1) US20230090177A1 (enExample)
EP (1) EP4157866A2 (enExample)
JP (2) JP2023530600A (enExample)
KR (1) KR20230017822A (enExample)
CN (1) CN115667294A (enExample)
AR (1) AR122496A1 (enExample)
AU (1) AU2021285802A1 (enExample)
BR (1) BR112022024472A2 (enExample)
CA (1) CA3182473A1 (enExample)
IL (1) IL298599A (enExample)
MX (1) MX2022014892A (enExample)
TW (2) TWI885439B (enExample)
WO (1) WO2021247457A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023264069A1 (en) 2022-05-03 2024-10-24 Genentech, Inc. Anti-ly6e antibodies, immunoconjugates, and uses thereof
CN115845083B (zh) * 2022-12-12 2025-04-11 南京逸微健华生物科技有限公司 一种靶向改造Expi293细胞外泌体递送siMMP13的方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE337223B (enExample) 1967-05-23 1971-08-02 Pharmacia Ab
US3720760A (en) 1968-09-06 1973-03-13 Pharmacia Ab Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
US3691016A (en) 1970-04-17 1972-09-12 Monsanto Co Process for the preparation of insoluble enzymes
CA1023287A (en) 1972-12-08 1977-12-27 Boehringer Mannheim G.M.B.H. Process for the preparation of carrier-bound proteins
US4195128A (en) 1976-05-03 1980-03-25 Bayer Aktiengesellschaft Polymeric carrier bound ligands
US4330440A (en) 1977-02-08 1982-05-18 Development Finance Corporation Of New Zealand Activated matrix and method of activation
CA1093991A (en) 1977-02-17 1981-01-20 Hideo Hirohara Enzyme immobilization with pullulan gel
US4229537A (en) 1978-02-09 1980-10-21 New York University Preparation of trichloro-s-triazine activated supports for coupling ligands
US4376110A (en) 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US5241053A (en) * 1990-09-05 1993-08-31 Takeda Chemical Industries, Ltd. Fused proteins comprising glycoprotein gD of HSV-1 and LTB
MX9204374A (es) 1991-07-25 1993-03-01 Idec Pharma Corp Anticuerpo recombinante y metodo para su produccion.
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
JP4939926B2 (ja) * 2003-02-14 2012-05-30 アノシス・インコーポレーテッド 抗体を生成し抗体レパートリーをスクリーニングするための方法とコンパウンド
US7871607B2 (en) 2003-03-05 2011-01-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
US20060104968A1 (en) 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
WO2013119602A1 (en) * 2012-02-06 2013-08-15 President And Fellows Of Harvard College Arrdc1-mediated microvesicles (armms) and uses thereof
US20190112351A1 (en) * 2016-04-04 2019-04-18 National Institutes Of Biomedical Innovation, Health And Nutrition Exosome-targeted dna vaccine
JP2019017341A (ja) * 2017-07-20 2019-02-07 国立研究開発法人国立がん研究センター 標識小胞及びその製造方法

Similar Documents

Publication Publication Date Title
AU2014232225B2 (en) Protocol for identifying and isolating antigen-specific B cells and producing antibodies to desired antigens
CN108490174B (zh) 检测car-t细胞的方法及其应用
RU2016103262A (ru) Способы идентификации иммунных связующих веществ поверхностных антигенов клетки
CN111426840A (zh) 一种新型冠状病毒检测试纸条及其制备方法和应用
US20100034807A1 (en) Methods and compositions for discovery of target-specific antibodies using antibody repertoire array (ara)
CN116640216B (zh) 抗cd19抗体的抗体、抗cd22抗体的抗体及其应用
JP2016031353A (ja) 肺炎マイコプラズマ検出試薬及びその用途
JP2023530600A5 (enExample)
CN118909110A (zh) Pcna结合蛋白、制备方法和应用
CN114414808A (zh) 一种检测tigit抗体和pvrig抗体的协同生物学活性的方法
CN115819595B (zh) 一种抗lag3纳米抗体及其制备方法与应用
CN116003606B (zh) 一种tigit纳米抗体及其制备方法与应用
WO2014096389A1 (en) Method for identifying antibody producing cells
CN119859189B (zh) 一种抗cd79b蛋白单克隆抗体及其相关产品和用途
CN117487004B (zh) 抗冠状病毒s蛋白的单克隆抗体及其应用
CN119899806B (zh) 一种用于检测抗Fc抗体的T细胞及其试剂盒、检测方法
CN113075403B (zh) 一种用于胃癌诊断的分子标记物及试剂盒
Yang et al. Use of CMFDA and CMTMR Fluorescent Dyes in FACS®-Based Antibody Screening
CN114966061B (zh) 一种抗ox40抗体的生物活性检测方法
CN116041527A (zh) 一种特异性结合e2-e2抗体复合物的抗体及其应用
JPWO2010090079A1 (ja) ストロムライシン1と特異的に反応するモノクローナル抗体
CN120157763A (zh) 一种抗γ9δ2TCR纳米抗体及其制备方法与应用
WO2026040803A1 (zh) 一种抗a型流感病毒的抗体及其应用
CN121471362A (zh) 一种结合寻常型天疱疮特异性抗原肽的抗体及其应用
WO2025229075A1 (en) A method for the specific determination of proenkephalin fragment 119-159